Clinical Development Stocks List

Clinical Development Stocks Recent News

Date Stock Title
May 7 AXSM Axsome (AXSM) Q1 Loss Widens Y/Y, Revenues Beat Estimates
May 7 AXSM Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q1 2024 Earnings Call Transcript
May 7 AUPH How Much Upside is Left in Aurinia (AUPH)? Wall Street Analysts Think 96.51%
May 7 ALNY Alnylam Issues 2023 Corporate Responsibility Report
May 7 AUPH Aurinia Will Attend 2024 RBC Capital Markets Global Healthcare Conference
May 7 AXSM Axsome Therapeutics Inc (AXSM) (Q1 2024) Earnings Call Transcript Highlights: Soaring Revenues ...
May 7 AXSM Q1 2024 Axsome Therapeutics Inc Earnings Call
May 6 AXSM Axsome Therapeutics (AXSM) Q1 2024 Earnings Call Transcript
May 6 AXSM Axsome Therapeutics, Inc. (AXSM) Q1 2024 Earnings Call Transcript
May 6 AXSM Axsome Therapeutics GAAP EPS of -$1.44 misses by $0.21, revenue of $75M beats by $2.15M
May 6 AXSM Axsome Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
May 5 ALNY The Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) First-Quarter Results Are Out And Analysts Have Published New Forecasts
May 4 BBIO What You Need To Know About The BridgeBio Pharma, Inc. (NASDAQ:BBIO) Analyst Downgrade Today
May 3 AUPH Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2024 Earnings Call Transcript
May 3 ALNY Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q1 2024 Earnings Call Transcript
May 3 AXSM Axsome Therapeutics Q1 2024 Earnings Preview
May 3 ALNY Alnylam (ALNY) Q1 Loss Narrower Than Expected, Sales Rise Y/Y
May 3 ALNY Alnylam Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations
May 3 AXSM Should You Buy Axsome Therapeutics (AXSM) Ahead of Earnings?
May 3 BBIO BridgeBio Pharma First Quarter 2024 Earnings: Beats Expectations
Clinical Development

Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.

Browse All Tags